Foghorn Therapeutics IncFHTX
Price$2.92

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value Insufficient data for a value estimatebased on filings through 30 Jun 2026
Market Price $2.92Price as of 1 Oct 2026
Data confidenceNot applicable

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: 5.0% (near-term consensus, capped) · years 2–5: 22.5%/yr (balance of the path).18.8% per year
Years 6–10: glide to demonstrated growth
Per-year rates
Yr 621.8%Yr 721.0%Yr 820.3%Yr 919.6%Yr 1018.8%
22.5% → 18.8%
Years 11–20: glide to long-run rate
Per-year rates
Yr 1117.2%Yr 1215.6%Yr 1314.1%Yr 1412.5%Yr 1510.9%Yr 169.3%Yr 177.7%Yr 186.2%Yr 194.6%Yr 203.0%
18.8% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Discount rate (cost of equity) 14.9%
Volatility vs market (adjusted beta)2.21

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetFoghorn Therapeutics IncFHTXHealth Care
Valuation
P/E—
P/S6.7×
P/B—
EV / Revenue4.8×
EV / EBITDA—
Profitability
Gross margin89.3%
Operating margin-265.7%
Net margin-175.8%
FCF margin-229.4%
Returns
ROE—
ROA-31.8%
ROIC—
Growth
Revenue growth (YoY)62.5%
5-yr fwd EPS growth18.8%
Financial strength
Debt / Equity—
Current ratio3.36×
Altman Z-Score-4.3
Interest coverage—
Dividend yield—

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.